Take your pick. No new sales in the US since July last year. A few punters with alternative uses for the money. But volumes, yesterday aside, are light.
FY is due the next couple of weeks, and I expect that it could surprise on the upside as some of the contracts enter their middle years and outperform view number expectations.
Bear in mind that, despite the hiatus in sales which is probably due to discretion with the new administration, all medical practices in the US are mandated to have medical records in an electronically transferable system by the end of next year and that 5 - 20% have done so, meaning that there is a potential tidal wave of signings that could happen between now and then.
At these levels I'm a buyer.
PME Price at posting:
$4.81 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)